Showing results (191-200 of 492) with videos related to
Sort By:
Pageof 50
Journal of Hepatology|September 21, 2014
Randomized study of danoprevir/ritonavir-based therapy for HCV genotype 1 patients with prior partial or null responses to peginterferon/ribavirinJordan J Feld, Ira M Jacobson, Donald M Jensen, et al.Hepatology (Baltimore, Md.)|October 21, 2014
Development and validation of a "capture-fusion" model to study drug sensitivity of patient-derived hepatitis CMorven E Cunningham, Alia Javaid, Jenny Waters, et al.Plos One|January 3, 2019
Safety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C in patients aged 65 years or olderGraham R Foster, Tarik Asselah, Sarah Kopecky-Bromberg, et al.Journal of Hepatology|September 2, 2015
Liver toxicity associated with sofosbuvir, an NS5A inhibitor and ribavirin useJessica K Dyson, John Hutchinson, Laura Harrison, et al.European Journal of Gastroenterology & Hepatology|August 5, 2016
Community nurse-led initiation of antiviral therapy for chronic hepatitis C in people who inject drugs does not increase uptake of or adherence to treatmentHeather Lewis, Jan Kunkel, David Axten, et al.Pulmonary Circulation|February 2, 2013
Endothelin-1 as a mediator and potential biomarker for interferon induced pulmonary toxicityPeter M George, Morven E Cunningham, Neil Galloway-Phillipps, et al.Liver International : Official Journal of the International Association for the Study of the Liver|January 3, 2021
Progress towards hepatitis C virus elimination in high-income countries: An updated analysisIvane Gamkrelidze, Jean-Michel Pawlotsky, Jeffrey V Lazarus, et al.Journal of Viral Hepatitis|September 8, 2020
Maintained virological suppression and renal function with reduced dose tenofovir disoproxil fumarate in renally impaired chronic hepatitis B patientsKin Seng Liem, David K Wong, Scott Fung, et al.Canadian Liver Journal|August 22, 2022
Non-surgical management of advanced hepatocellular carcinoma: A systematic review by Cancer Care OntarioBrandon M Meyers, Jennifer J Knox, Roxanne Cosby, et al.CMAJ Open|January 10, 2023
Cost-effectiveness modelling of birth and infant dose vaccination against hepatitis B virus in Ontario from 2020 to 2050Mia J Biondi, Chris Estes, Devin Razavi-Shearer, et al.Pageof 50